Polaris Management Co. VII, L.L.C. bought $10.0M of CAMP4 THERAPEUTICS (CAMP)
Executed Oct 15 2024, disclosed Oct 22 2024, 7 days later, against a two-business-day limit.
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
Polaris Management Co. VII, L.L.C. (10% owner) filed 2 Form 4 reports as a reporting entity in the past 24 months (2 purchases, 0 sales, 1 filed past the two-business-day deadline), most often in CAMP4 THERAPEUTICS CORPORATION (CAMP). Across 1 priced purchase filing, the average 21-session return was +44.7% from execution and +44.7% from disclosure (delay-adjusted; derived). The largest single filing was $10.0M of CAMP (909,090 sh × $11.00, as filed), executed Oct 15 2024.
Healthcare · Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→1,307,189 sh across 2 lots
Exec Sep 11 2025
Filed Sep 11 2025 · 4:59 PM ET